Puma Biotechnology, Inc. (PBYI) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Puma Biotechnology, Inc. (PBYI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $364.9M, listed on NASDAQ, employing roughly 172 people, carrying a beta of 1.23 to the broader market. Puma Biotechnology, Inc. Led by Alan H. Auerbach, public since 2012-04-24.
Snapshot as of May 15, 2026.
- Spot Price
- $6.93
- Total OI
- 4.6K